Novacyt is a rapidly growing, international diagnostics group, generating revenues from the sale of diagnostic and pathogen testing kits based on molecular and protein testing technologies and sold into human clinical, life science, food and industrial markets.

Our Latest News

26 November 2021

Approval of COVID-19 test in the UK under CTDA legislation


Update on Novacyt's qPCR assays against the Omicron variant

Our 2020 Annual Report